Tetronic®904-containing polymeric micelles overcome the overexpression of ABCG2 in the blood–brain barrier of rats and boost the penetration of the antiretroviral efavirenz into the CNS

Antiretroviral Therapeutic Drug Monitoring in HIV-Infected Pregnant Women: Maternal Immunovirological Outcome at Delivery and During the 18 Month Follow-Up Period

(2016) Emanuele Nicastri et al.   CURRENT HIV RESEARCH

Enabling nanomaterial, nanofabrication and cellular technologies for nanoneuromedicines

(2015) Surya K. Mallapragada et al.   Nanomedicine-Nanotechnology Biology and Medicine

Reversal of multidrug resistance by the inhibition of ATP-binding cassette pumps employing “Generally Recognized As Safe” (GRAS) nanopharmaceuticals: A review

(2013) Alejandro Sosnik   ADVANCED DRUG DELIVERY REVIEWS

Induction of P-Glycoprotein by Antiretroviral Drugs in Human Brain Microvessel Endothelial Cells

(2013) Gary N. Y. Chan et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Transporter Studies in Drug Development: Experience to Date and Follow-Up on Decision Trees From the International Transporter Consortium

(2013) D Tweedie et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Overview of P-glycoprotein inhibitors: a rational outlook

(2012) Kale Mohana Raghava Srivalli et al.   Brazilian Journal of Pharmaceutical Sciences

Intranasal administration of antiretroviral-loaded micelles for anatomical targeting to the brain in HIV

(2012) Diego A Chiappetta et al.   Nanomedicine

Integrating tuberculosis and HIV services in low- and middle-income countries: a systematic review

(2012) Helena Legido-Quigley et al.   TROPICAL MEDICINE & INTERNATIONAL HEALTH

Nanotechnology and the Treatment of HIV Infection

(2012) Raveen Parboosing et al.   Viruses-Basel

Efavirenz is a substrate and in turn modulates the expression of the efflux transporter ABCG2/BCRP in the gastrointestinal tract of the rat

(2011) Roxana N. Peroni et al.   BIOCHEMICAL PHARMACOLOGY

Utility of therapeutic drug monitoring in the management of HIV-infected pregnant women in receipt of lopinavir

(2011) R J Caswell et al.   INTERNATIONAL JOURNAL OF STD & AIDS

Poloxamines Display a Multiple Inhibitory Activity of ATP-Binding Cassette (ABC) Transporters in Cancer Cell Lines

(2011) María L. Cuestas et al.   MOLECULAR PHARMACEUTICS

Synergistic encapsulation of the anti-HIV agent efavirenz within mixed poloxamine/poloxamer polymeric micelles

(2011) Diego A. Chiappetta et al.   Nanomedicine-Nanotechnology Biology and Medicine

ABC Transporters and Drug Efflux at the Blood-Brain Barrier

(2011) Shanshan Shen et al.   REVIEWS IN THE NEUROSCIENCES

Oral pharmacokinetics of the anti-HIV efavirenz encapsulated within polymeric micelles

(2010) Diego A. Chiappetta et al.   BIOMATERIALS

A Highly Concentrated and Taste-Improved Aqueous Formulation of Efavirenz for a More Appropriate Pediatric Management of the Anti-HIV Therapy

(2010) Diego A. Chiappetta et al.   CURRENT HIV RESEARCH

Inhibition of P-glycoprotein pumps by PEO–PPO amphiphiles: branched versus linear derivatives

(2010) Carmen Alvarez-Lorenzo et al.   Nanomedicine

Neurologic disease burden in treated HIV/AIDS predicts survival: A population-based study

(2010) P. Vivithanaporn et al.   NEUROLOGY

In Vivo Methods to Study Uptake of Nanoparticles into the Brain

(2010) Inge van Rooy et al.   PHARMACEUTICAL RESEARCH

Efavirenz-loaded polymeric micelles for pediatric anti-HIV pharmacotherapy with significantly higher oral bioavailability

(2009) Diego A Chiappetta et al.   Nanomedicine

Neuropsychological Functioning and Antiretroviral Treatment in HIV/AIDS: A Review

(2009) Lucette A. Cysique et al.   NEUROPSYCHOLOGY REVIEW

Antiviral efficacy, tolerability and pharmacokinetics of efavirenz in an unselected cohort of HIV-infected children

(2008) U. Wintergerst et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Hide-and-Seek: The Challenge of Viral Persistence in HIV-1 Infection

(2007) Luc Geeraert et al.   Annual Review of Medicine